Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation Myocardial Infarction? A Literature Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2019 Aug 20

PMID 31423405

Citations 28

Authors

Ishan Poudel

Chavi Tejpal

Hamza Rashid

Nusrat Jahan

Affiliations

Soon will be listed here.

Abstract

Major adverse cardiovascular events (MACE) remain the major cause of mortality and morbidity in patients with STEMI (ST-elevation myocardial infarction). The current literature is aimed to analyze the occurrence of MACE following STEMI irrespective of treatment provided, and follow up after the first diagnosis of STEMI. A PubMed search for Studies of STEMI identified 24,244 articles. After applying our inclusion/exclusion criteria, we found out 75 articles of relevance wherein MACE and its components were considered to be the primary endpoint. These 75 articles included eight Cohort Studies, 13 clinical trials including five randomized controlled trials (RCT), one case-control Study, one cross-sectional study, one review article, and 51 other observational studies. Our analysis shows that MACE remains one of the strongest adverse outcomes among STEMI patients. The current literature review found out the incidence of MACE was 4.2 % to 51% irrespective of the mode of treatment, and follow-ups lasting up to 10 years from the time of STEMI diagnosis.

Citing Articles

Quantitative aortic Na[F]F positron emission tomography computed tomography as a tool to associate vascular calcification with major adverse cardiovascular events.

Lieverse T, van Praagh G, Mulder D, Lambers Heerspink H, Wolterink J, Slart R Eur J Nucl Med Mol Imaging. 2024; 52(2):501-509.

PMID: 39297960 PMC: 11732873. DOI: 10.1007/s00259-024-06901-9.

Discrepancies between Coronary Artery Calcium Score and Coronary Artery Disease Severity in Computed Tomography Angiography Studies.

Gac P, Jaworski A, Parfianowicz A, Karwacki J, Wysocki A, Poreba R Diagnostics (Basel). 2024; 14(17).

PMID: 39272713 PMC: 11394150. DOI: 10.3390/diagnostics14171928.

Impact of complete versus culprit-only revascularization on major adverse cardiovascular event in diverse subpopulations.

Ansari H, Dar F, Shaikh N, Noman A, Ahmed K, Asad U Future Cardiol. 2024; 20(11-12):627-637.

PMID: 39230509 PMC: 11520548. DOI: 10.1080/14796678.2024.2387516.

Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta analysis.

Hamayal M, Shahid W, Akhtar C, Shekiba F, Iftikhar I, Tahir M Future Cardiol. 2024; 20(11-12):639-650.

PMID: 39140596 PMC: 11520570. DOI: 10.1080/14796678.2024.2388478.

Comparing clinical outcomes of patients with severe lower limb trauma undergoing orthoplastic and orthopedic surgeries: A long-term study protocol.

Yang Z, Xu C, Zhu Y, Tan Y, Hu H, Fang P Heliyon. 2024; 10(13):e33589.

PMID: 39035506 PMC: 11259889. DOI: 10.1016/j.heliyon.2024.e33589.

References

Hermans W, Foley D, Rensing B, Rutsch W, Heyndrickx G, Danchin N . Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups. Am J Cardiol. 1993; 72(1):14-20. DOI: 10.1016/0002-9149(93)90211-t. View

Li G, Zhou B, Qi G, Zhang B, Jiang D, Wu G . Current Trends for ST-segment Elevation Myocardial Infarction during the Past 5 Years in Rural Areas of China's Liaoning Province: A Multicenter Study. Chin Med J (Engl). 2017; 130(7):757-766. PMC: 5381308. DOI: 10.4103/0366-6999.202742. View

Wei P, Fu Q, Tao Z, Han B, Zhang Y, Huang Y . Relationship between B-type natriuretic peptide and short-term prognosis in non-diabetic patients with ST-segment elevation myocardial infarction. Eur Rev Med Pharmacol Sci. 2016; 20(4):721-5. View

Lonborg J, Kelbaek H, Engstrom T, Helqvist S, Klovgaard L, Holmvang L . ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial. EuroIntervention. 2014; 10(4):466-74. DOI: 10.4244/EIJV10I4A80. View

Thygesen K, Alpert J, Jaffe A, Simoons M, Chaitman B, White H . Third universal definition of myocardial infarction. Glob Heart. 2015; 7(4):275-95. DOI: 10.1016/j.gheart.2012.08.001. View

Grundeken M, Lu H, Vos N, Ijsselmuiden A, van Geuns R, Wessely R . One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study. J Invasive Cardiol. 2017; 29(8):253-258. View

van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A . Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014; 7(9):930-9. DOI: 10.1016/j.jcmg.2014.05.010. View

OGara P, Kushner F, Ascheim D, Casey Jr D, Chung M, de Lemos J . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012; 127(4):529-55. DOI: 10.1161/CIR.0b013e3182742c84. View

Qi Q, Niu J, Chen T, Yin H, Wang T, Jiang Z . Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction. Med Sci Monit. 2018; 24:2767-2776. PMC: 5954842. DOI: 10.12659/MSM.906815. View

10.

Hassan A, Dimitry S, Agban G . Can exercise capacity assessed by the 6 minute walk test predict the development of major adverse cardiac events in patients with STEMI after fibrinolysis?. PLoS One. 2014; 9(6):e99035. PMC: 4048282. DOI: 10.1371/journal.pone.0099035. View

11.

Liu H, Chen M, Yu J, Li W, Tao L, Li Y . Serum apelin level predicts the major adverse cardiac events in patients with ST elevation myocardial infarction receiving percutaneous coronary intervention. Medicine (Baltimore). 2015; 94(4):e449. PMC: 4602953. DOI: 10.1097/MD.0000000000000449. View

12.

Ribeiro D, Ramos A, Vieira P, Menti E, Bordin Jr O, Souza P . High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. Arq Bras Cardiol. 2014; 103(1):69-75. PMC: 4126763. DOI: 10.5935/abc.20140086. View

13.

Barton G, Irvine L, Flather M, McCann G, Curzen N, Gershlick A . Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention. Value Health. 2017; 20(6):745-751. DOI: 10.1016/j.jval.2017.02.002. View

14.

Reinstadler S, Klug G, Feistritzer H, Kofler M, Pernter B, Gobel G . Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2015; 17(2):169-76. PMC: 4882876. DOI: 10.1093/ehjci/jev129. View

15.

Cheng Y, Liu T, Lai H, Lee W, Ho H, Su C . Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study. BMC Cardiovasc Disord. 2014; 14:143. PMC: 4197277. DOI: 10.1186/1471-2261-14-143. View

16.

Yang L, Zheng T, Wu H, Xin W, Mou X, Lin H . Predictive value of apelin-12 in patients with ST-elevation myocardial infarction with different renal function: a prospective observational study. BMJ Open. 2017; 7(11):e018595. PMC: 5701982. DOI: 10.1136/bmjopen-2017-018595. View

17.

Park S, Moon J, Kwon S, Suh Y, Kim T, Jang H . Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry. PLoS One. 2016; 11(7):e0159416. PMC: 4945029. DOI: 10.1371/journal.pone.0159416. View

18.

Park H, Kim H, Jeong M, Cho J, Lee K, Sim D . Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention. J Cardiol. 2016; 69(1):216-221. DOI: 10.1016/j.jjcc.2016.03.012. View

19.

Gruberg L, Hellkamp A, Thomas L, de Lemos J, Scirica B, Hilliard A . The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2016; 8(15):1954-1962. DOI: 10.1016/j.jcin.2015.08.030. View

20.

Liu H, Han Y, Jin Q, Wang X, Ma Y, Wang G . One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention. Chin Med J (Engl). 2018; 131(12):1412-1419. PMC: 6006809. DOI: 10.4103/0366-6999.233948. View